179 related articles for article (PubMed ID: 31195985)
1. Medication patterns in older adults with multimorbidity: a cluster analysis of primary care patients.
Guisado-Clavero M; Violán C; López-Jimenez T; Roso-Llorach A; Pons-Vigués M; Muñoz MA; Foguet-Boreu Q
BMC Fam Pract; 2019 Jun; 20(1):82. PubMed ID: 31195985
[TBL] [Abstract][Full Text] [Related]
2. Multimorbidity patterns in the elderly: a prospective cohort study with cluster analysis.
Guisado-Clavero M; Roso-Llorach A; López-Jimenez T; Pons-Vigués M; Foguet-Boreu Q; Muñoz MA; Violán C
BMC Geriatr; 2018 Jan; 18(1):16. PubMed ID: 29338690
[TBL] [Abstract][Full Text] [Related]
3. Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.
Tan YY; Papez V; Chang WH; Mueller SH; Denaxas S; Lai AG
Lancet Healthy Longev; 2022 Oct; 3(10):e674-e689. PubMed ID: 36150402
[TBL] [Abstract][Full Text] [Related]
4. Survival in relation to multimorbidity patterns in older adults in primary care in Barcelona, Spain (2010-2014): a longitudinal study based on electronic health records.
Ibarra-Castillo C; Guisado-Clavero M; Violan-Fors C; Pons-Vigués M; López-Jiménez T; Roso-Llorach A;
J Epidemiol Community Health; 2018 Mar; 72(3):185-192. PubMed ID: 29330165
[TBL] [Abstract][Full Text] [Related]
5. Combined Multimorbidity and Polypharmacy Patterns in the Elderly: A Cross-Sectional Study in Primary Health Care.
Stafford G; Villén N; Roso-Llorach A; Troncoso-Mariño A; Monteagudo M; Violán C
Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501805
[TBL] [Abstract][Full Text] [Related]
6. Soft clustering using real-world data for the identification of multimorbidity patterns in an elderly population: cross-sectional study in a Mediterranean population.
Violán C; Foguet-Boreu Q; Fernández-Bertolín S; Guisado-Clavero M; Cabrera-Bean M; Formiga F; Valderas JM; Roso-Llorach A
BMJ Open; 2019 Aug; 9(8):e029594. PubMed ID: 31471439
[TBL] [Abstract][Full Text] [Related]
7. Multimorbidity patterns with K-means nonhierarchical cluster analysis.
Violán C; Roso-Llorach A; Foguet-Boreu Q; Guisado-Clavero M; Pons-Vigués M; Pujol-Ribera E; Valderas JM
BMC Fam Pract; 2018 Jul; 19(1):108. PubMed ID: 29969997
[TBL] [Abstract][Full Text] [Related]
8. Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysis.
Menditto E; Gimeno Miguel A; Moreno Juste A; Poblador Plou B; Aza Pascual-Salcedo M; Orlando V; González Rubio F; Prados Torres A
PLoS One; 2019; 14(2):e0210701. PubMed ID: 30726245
[TBL] [Abstract][Full Text] [Related]
9. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
[TBL] [Abstract][Full Text] [Related]
10. Patterns of multimorbidity and pharmacotherapy: a total population cross-sectional study.
Forslund T; Carlsson AC; Ljunggren G; Ärnlöv J; Wachtler C
Fam Pract; 2021 Mar; 38(2):132-140. PubMed ID: 32766818
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project).
Prados-Torres A; Del Cura-González I; Prados-Torres D; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; López-Verde F; Gimeno-Feliu LA; Escortell-Mayor E; Pico-Soler V; Sanz-Cuesta T; Bujalance-Zafra MJ; Morey-Montalvo M; Boxó-Cifuentes JR; Poblador-Plou B; Fernández-Arquero JM; González-Rubio F; Ramiro-González MD; Coscollar-Santaliestra C; Martín-Fernández J; Barnestein-Fonseca MP; Valderas-Martínez JM; Marengoni A; Muth C;
Implement Sci; 2017 Apr; 12(1):54. PubMed ID: 28449721
[TBL] [Abstract][Full Text] [Related]
12. Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland.
Linnet K; Gudmundsson LS; Birgisdottir FG; Sigurdsson EL; Johannsson M; Tomasdottir MO; Sigurdsson JA
BMC Fam Pract; 2016 Jun; 17():69. PubMed ID: 27267943
[TBL] [Abstract][Full Text] [Related]
13. Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study.
Villén N; Guisado-Clavero M; Fernández-Bertolín S; Troncoso-Mariño A; Foguet-Boreu Q; Amado E; Pons-Vigués M; Roso-Llorach A; Violán C
BMC Geriatr; 2020 Jun; 20(1):206. PubMed ID: 32532213
[TBL] [Abstract][Full Text] [Related]
14. Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice.
von Buedingen F; Hammer MS; Meid AD; Müller WE; Gerlach FM; Muth C
BMC Fam Pract; 2018 Jul; 19(1):131. PubMed ID: 30055583
[TBL] [Abstract][Full Text] [Related]
15. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
McIntyre C; McQuillan R; Bell C; Battistella M
Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
[TBL] [Abstract][Full Text] [Related]
16. Non-random relations in drug use expressed as patterns comprising prescription and over-the-counter drugs in multimorbid elderly patients in primary care: Data of the exploratory analysis of the multicentre, observational cohort study MultiCare.
Krüger C; Schäfer I; van den Bussche H; Baehr M; Bickel H; Fuchs A; Gensichen J; Maier W; Riedel-Heller SG; König HH; Dahlhaus A; Schön G; Weyerer S; Wiese B; von Renteln-Kruse W; Langebrake C; Scherer M
Eur J Gen Pract; 2021 Dec; 27(1):119-129. PubMed ID: 34132623
[TBL] [Abstract][Full Text] [Related]
17. Prescription Medication Use in Older Adults Without Major Cardiovascular Disease Enrolled in the Aspirin in Reducing Events in the Elderly (ASPREE) Clinical Trial.
Lockery JE; Ernst ME; Broder JC; Orchard SG; Murray A; Nelson MR; Stocks NP; Wolfe R; Reid CM; Liew D; Woods RL;
Pharmacotherapy; 2020 Oct; 40(10):1042-1053. PubMed ID: 33078479
[TBL] [Abstract][Full Text] [Related]
18. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.
Baré M; Herranz S; Jordana R; Gorgas MQ; Ortonobes S; Sevilla D; De Jaime E; Ibarra O; Martín C;
BMJ Open; 2020 Jan; 10(1):e033322. PubMed ID: 31988230
[TBL] [Abstract][Full Text] [Related]
19. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
[TBL] [Abstract][Full Text] [Related]
20. Potentially inappropriate prescribing (IP) for elderly medical inpatients in Taiwan: a hospital-based study.
Liu CL; Peng LN; Chen YT; Lin MH; Liu LK; Chen LK
Arch Gerontol Geriatr; 2012; 55(1):148-51. PubMed ID: 21820189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
